LPA promotes the interaction of GNA12 and EFA6 through LPAR2 and activates the ADP-ribosylation factors 6-based pathway, consequently promoting the invasion of renal cancer cells (Hashimoto et al. 2016). Here, PSD is linked to renal carcinoma.